Skip to main content
logo
Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.637
0.00 (0.00%)
Sep 2, 2026, 9:46 AM EDT - Market open

Alzamend Neuro Cash Flow Statement

Millions USD. Fiscal year is May - Apr.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Net Income
-8.77-4.51-9.95-14.88-12.36
Depreciation & Amortization
0.110.050.050.020
Stock-Based Compensation
0.710.330.963.584.41
Other Operating Activities
-0.010-0.01
Change in Accounts Payable
0.71-2.290.051.710.69
Change in Other Net Operating Assets
-0.83-0.150.620.640.63
Operating Cash Flow
-8.07-6.57-8.27-8.92-6.61
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Capital Expenditures
--0.3-0.15--0.11
Investing Cash Flow
--0.3-0.15--0.11

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Short-Term Debt Issued
--0.3--
Total Debt Issued
--0.3--
Short-Term Debt Repaid
-----0.06
Total Debt Repaid
-----0.06
Net Debt Issued (Repaid)
--0.3--0.06
Issuance of Common Stock
0.792.71.25018.91
Financing Cash Flow
4.8310.443.65018.85

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Net Cash Flow
-3.243.57-4.76-8.9212.13

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Free Cash Flow
-8.07-6.87-8.42-8.92-6.72
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-2.42-15.24-111.97-123.53-101.83
Levered Free Cash Flow
-4.78-5.19-4.69-4.33-2.19
Unlevered Free Cash Flow
-4.77-5.17-4.68-4.33-2.16

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Change in Working Capital
-0.11-2.440.672.351.33
SEC Filings: 10-K · 10-Q